Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

Citius Oncology at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Citius Oncology at ASH 2026 in New Orleans: Booth 3255.

OrganizationASH 2026 Attendance
Citius Oncology
Cranford, NJ
citiusonc.com/overview/default.aspx
Biotech
Oncology company, majority owned by Citius Pharmaceuticals, marketing LYMPHIR (denileukin diftitox), an FDA-approved immunotherapy for relapsed cutaneous T-cell lymphoma.
Booth
Exhibiting at Booth 3255
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Citius Oncology

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction